The New Normal Fund

New Normal Ventures, led by Allison Pickens, focuses on scaling B2B SaaS companies. The fund is known for its strong emphasis on growing Annual Recurring Revenue (ARR) and preparing startups for pre-IPO stages. Key investments include dbt Labs, Vitable Health, and Mural, showcasing their commitment to transformative software companies. Their industry focus is predominantly on B2B SaaS, emphasizing customer-centric growth and scalable business models. Geographically, New Normal Ventures targets startups across the United States, supporting them through various growth stages with substantial operational expertise and strategic guidance. The investment strategy of New Normal Ventures centers on high-impact, growth-oriented investments. They provide not just capital but also hands-on support, leveraging Allison Pickens' extensive network and experience. The firm is known for its proactive approach in leading rounds and assembling advisory boards to guide startups. They typically engage early and stay deeply involved, ensuring startups receive the mentorship and resources needed to navigate complex growth challenges. Allison Pickens, the driving force behind the fund, brings a wealth of experience from her time as COO at Gainsight and as a leading figure in the customer success movement. Her strategic insights and vast network make her an invaluable partner to startups, often helping them secure follow-on funding and scale effectively. For startups looking to engage with New Normal Ventures, having a clear growth strategy, strong ARR potential, and a customer-centric approach are crucial. The firm values warm introductions and places significant importance on the founding team’s vision and ability to execute.